Leclanche SA revised earnings guidance for the fiscal year 2012. Despite an increase in revenues expected in 2012, particularly in the Lithium Ion Technology unit, the net loss in 2012 will now be higher than last year.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.572 CHF | +0.35% | -1.38% | +16.73% |
May. 02 | Leclanché to Start Testing PFAS-free Battery Cells | MT |
Apr. 30 | Leclanché Gets Extension for Publication of FY23 Results; Reports Decline in Unaudited Net Loss | MT |
1st Jan change | Capi. | |
---|---|---|
+16.73% | 367M | |
+23.46% | 122B | |
-14.74% | 62.57B | |
-12.82% | 20B | |
+11.18% | 18.26B | |
-29.34% | 14.58B | |
-12.11% | 10.46B | |
+2.56% | 5.43B | |
+3.51% | 4.56B | |
-3.43% | 3.92B |
- Stock Market
- Equities
- LECN Stock
- News Leclanché SA
- Leclanche SA Revises Earnings Guidance for the Fiscal Year 2012